Notice of server maintenance. Membership dues payment will be offline for 24 hours. Check back on Thursday afternoon if you wish to pay your dues.

International Xenotransplantation Association Update

The Joint Congress of IPITA, IXA, and CTS, held in Melbourne, Australia in November 2015, was a great success both scientifically and socially. Joint plenaries reaffirmed the significant synergies between the 3 Sections, while the packed IXA-specific program stream highlighted several major advances in xenotransplantation, which were the subject of a press release. It was clear from numerous presentations that the rapid development of techniques for precise genetic engineering continues apace, with the promise of further prolongation of xenograft survival and the minimization of infectious risk. IXA provided a number of travel awards to allow young members to attend and present their work, and the Vanguard Committee, chaired by Chris Burlak, worked with the other Sections to hold a very well attended young investigator session, followed by a networking event. IXA also sponsored presentations by the 2015 IXA Honorary Member (Uri Galili) and the inaugural Reemtsma Lecturer (Mark Hardy), adding a historical perspective to the program.

The incoming IXA Council consists of President Peter Cowan (Australia), President-Elect Leo Bühler (Switzerland), Secretary/Treasurer Agnes Azimzadeh (USA), Immediate Past President Takaaki Kobayashi (Japan), and councilors Curie Ahn (South Korea), Wayne Hawthorne (Australia), Shuji Miyagawa (Japan), Muhammad Mohiuddin (USA), David Sachs (USA), and Eckard Wolf (Germany).

Council’s goals in 2016-17 include continuing to expand the membership and provide more opportunities and benefits to members, promoting the active involvement of younger members, and ensuring that regulatory and ethical frameworks develop in line with advances in the field. Members are warmly encouraged to contact the President or other members of Council with any new ideas and suggestions.  

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi